This site is intended for Healthcare professionals only.
×

Lupin gets USFDA approval for generic Ortho-Cyclen tablets


Lupin gets USFDA approval for generic Ortho-Cyclen tablets

Mumbai : Pharma major Lupin Ltd has received final approval from the USFDA to market norg-estimate and ethinyl estradiol tablets marked for use by females of reproductive potential to prevent pregnancy.

“We have received final approval for norg-estimate and ethinyl estradiol tablets USP, 0.25 mg/0.035 mg, from the United States Food and Drug Administration (FDA) to market a generic version of Janssen Pharmaceuticals Ortho-Cyclen 28 tablets,” a company statement said today.

The approved product will be manufactured at Lupin’s Pithampur facility. It is indicated for use by females of reproductive potential to prevent pregnancy. Ortho-Cyclen tablets had US sales of USD 178.2 million.

Lupin is an innovation-led transnational pharmaceutical company developing and delivering a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.

The following two tabs change content below.
savita thakur

savita thakur

Studied at Indraprastha College for Women (Delhi University), completed in 2014. Currently working with Medical Dialogues, a online Medical news paper dedicated for healthcare Professionals.


Source: PTI
0 comment(s) on Lupin gets USFDA approval for generic Ortho-Cyclen tablets

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted